Sisätautien klinikka

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Airaksinen J. Ovatko tulehduskipulääkkeet vaarallisia sydänpotilaalle?
2 Airaksinen J. Kardiologia Suomessa vuonna 2004 - ongelmia ja kehitysmahdollisuuksia.
3 Airaksinen KEJ et al. Diabetes and haemodynamic reactions to acute coronary occlusion.
4 Aittoniemi J et al. The effect of mannan-binding lectin variant alleles on coronary artery reactivity in healthy young men.
5 Burke AP et al. Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans.
6 Eerola E et al. The gastrointestinal tract.
7 Färkkilä M et al. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial.
8 Gorman JD et al. Impact of shared epitope genotype and ethnicity on erosive disease. A meta-analysis of 3,240 rheumatoid arthritis patients.
9 Haaparanta M et al. In vivo sampling for pharmacokinetic studies in small experimental animals: a combination of microdialysis, planar chromatography and digital autoradiography.
10 Hadziyannis SJ et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C. A Randomized study of treatment duration and ribavirin dose.
11 Hakanen M et al. Serum leptin concentration poorly reflects growth and energy and nutrient intake in young children.
12 Hermansen K et al. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system. A 12-week proof-of-concept trail in patients with type 2 diabetes.
13 Hognestad A et al. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure.
14 Hohenthal U et al. Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: A Study on Patients Treated in a Finnish University Hospital.
15 Hoieggen A et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
16 Hutter R et al. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages. Evidence for apoptosis as link between inflammation and atherothrombosis.
17 Hällsten K. Glucose Uptake in Skeletal Muscle and Myocardium in Insulin Resistance. The Effect of Rosiglitazone Treatment.
18 Hällsten K et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.
19 Immonen-Räihä P. Nuoren naisen hypertyreoosi.
20 Iozzo P. Metabolic Regulation of Liver Glucose Uptake in Humans. Positron Emission Tomography Studies with Reference to Diabetes.
21 Iozzo P et al. Non-esterified fatty acids impair insulin-mediated glucose uptake and disposition in the liver.
22 Iozzo P et al. Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia.
23 Iozzo P et al. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance.
24 Itälä M et al. Reduced-intensity conditioning and blood stem cell trasplantation form an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other.
25 Itälä M, Remes K. Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment.
26 Jalanko H et al. Mikrobilääkehoidon opas 2004.
27 Jalava J, Marttila H. Application of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug-resistant Mycobacterium tuberculosis.
28 Janatuinen T et al. Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.
29 Jantunen E et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
30 Jantunen E et al. Autologous stem cell transplantation in patients with primary amyloidosis: A Nation-wide survey.
31 Jantunen E et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
32 Johansson B-L et al. C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients.
33 Julius S et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
34 Juonala M et al. The 21-year follow-up of the cardiovascular risk in young Finns study: risk factor levels, secular trends and east-west difference.
35 Juonala M et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults. The cardiovascular risk in young Finns study.
36 Juutilainen A et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
37 Järveläinen H et al. Rautahoitoon reagoimaton hypokrominen mikrosyyttinen anemia nuorella naisella.
38 Järveläinen H et al. Overexpression of decorin by rat arterial smooth muscle cells enhances contraction of type I collagen in vitro.
39 Järvisalo MJ et al. Endothelial dysfunction and increased arterial intima-media thickness in children with Type 1 diabetes.
40 Kalliokoski KK et al. Blood transit time heterogeneity is associated to oxygen extraction in exercising human skeletal muscle.
41 Kalliokoski KK et al. Myocardial perfusion after marathon running.
42 Kantola I. Muuttuuko verenpaineen hoito? Kun hoidat, hoida tehokkaasti.
43 Kantola I. Kohonneen verenpaineen lääkehoito - Tiedettä ja taidetta.
44 Kantola I. Angiotensiinireseptorin salpaajako kohonneen verenpaineen hoitoon?
45 Kauhava L et al. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme.
46 Kauhava L et al. Mammografiaseulonta alentaa rintasyövän sairaalahoidon kustannuksia.
47 Kiviniemi TO et al. Coronary artery diameter can be assessed reliably with transthoracic echocardiography.
48 Knuuti J et al. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronisation therapy.
49 Korpela M et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Five-year experience from the FIN-RACo Study.
50 Koskela K et al. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotheraphy: a phase I/II trial.
51 Kotilainen P et al. Positron emission tomography as an aid in the diagnosis and follow-up of Riedel's thyroiditis.
52 Kozák-Bárany A et al. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control.
53 Kronqvist P et al. Predicting aggressive outcome in T1N0M0 breast cancer.
54 Kunnas TA et al. Estrogen receptor genotype modulates myocardial perfusion in young men.
55 Kupila L et al. Recurrent lymphocytic meningitis. The role of herpesviruses.
56 Laine H et al. Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes.
57 Laine M et al. Sindbis viruses and other alphaviruses as cause of human arthritic disease.
58 Laivoranta-Nyman S et al. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
59 Lehtonen A et al. Declining incidence and mortality of stroke in persons aged >/= 75 years in Finland; the FINSTROKE study.
60 Leino R. Tahaton laihtuminen.
61 Leino R. Yersinioosi.
62 Liutu M et al. Mast cells and IgE-containing cells in gastric mucosa of Helicobacter pylori infected and non-infected patients with chronic urticaria.
63 Luukinen H et al. Orthostatic hypotension and the risk of myocardial infarction in the home-dwelling elderly.
64 Mikkilä V et al. Longitudinal changes in diet from childhood into adulthood with respect to risk of cardiovascular diseases: The Cardiovascular risk in young Finns study.
65 Minn H et al. Imaging of adrenal incidentalomas with PET using 11C-metomidate and 18F-FDG.
66 Mähönen MS et al. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA project populations.
67 Mäkelä R et al. Myeloperoxidase gene variation and coronary flow reserve in young healthy men.
68 Möttönen T. Uskaltaako kortisonia käyttää, kun se pehmentää luut?
69 Niiranen T et al. Kandesartaanin ja kandesartaanihydroklooritiatsidiyhdistelmän antihypertensiivinen vaikutus.
70 Niklason A et al. Development of diabetes is retarded by ACE inhibition in hypertensive patients - a subanalysis of the Captopril Prevention Project (CAPPP).
71 Oikarinen L et al. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy. The losartan intervention for endpoint reduction in hypertension study.
72 Okin PM et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
73 Okin PM et al. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiopraphic left ventricular mass: the LIFE study.
74 Penttinen M et al. Fabryn tauti ja suositus sen diagnostiikasta, seurannasta ja hoitolinjoista Suomessa.
75 Puolakka K et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early Rheumatoid Arthritis. A five-year randomized followup trial.
76 Reims HM et al. Alcohol comsumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
77 Ruottinen S et al. Sucrose intake since infancy and dental health in 10-year-old children.
78 Ruutu T et al. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
79 Räsänen M et al. Impact of nutrition counselling on nutrition knowledge and nutrient intake of 7- to 9-y-old children in an atherosclerosis prevention project.
80 Saarela E et al. Ruokatorven kautta tehtävä sydämen kaikukuvaus eteisvärinän rytminsiirrossa.
81 Saario R. Epäilen sidekudostautia: mitkä vasta-aineet tutkin?
82 Sarkola A et al. Prospective evaluation of the GenoType Assay for routine identification of mycobacteria.
83 Savontaus M et al. Abnormal craniofacial development and expression patterns of extracellular matrix components in transgenic Dell mice harboring a deletion mutation in the type II collagen gene.
84 Sipponen P et al. Atrofiseen gastriittiin liittyvä matala seerumin B12-vitamiinitaso - vanhenevien miesten terveysriski.
85 Sivenius J et al. Continous 15-year decrease in incidence and mortality of stroke in Finland. The FINSTROKE study.
86 Sivenius J et al. FINSTROKE-tutkimus: Aivohalvauksen ilmaantuvuus ja kuolleisuus laskivat Suomessa vuosina 1983 - 1997.
87 Soinio M et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 Diabetes Mellitus.
88 Stolen KQ et al. Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy.
89 Stolen KQ et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy.
90 Sumanen M et al. Secondary prevention of coronary heart disease is disappointing among patients of working age.
91 Sundell J et al. Keuhkokasvaimen aiheuttama hypoglykemia.
92 Sundell J et al. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
93 Sundell J, Luotolahti M. Association between insulin resistance and reduced coronary vasoreactivity in healthy subjects.
94 Sundell J et al. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes.
95 Sundell J et al. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.
96 Sääkslahti A et al. Physical activity as a preventive measure for coronary heart disease risk factors in early childhood.
97 Säämänen J. Sydämenpysähdyspotilaan peruselvytys sairaalassa. Elvytyskoulutuksen ja taustamuuttujien yhteys sairaanhoitajien elvytystietoihin ja -taitoihin.
98 Talvia S et al. A randomized intervention since infancy to reduce intake of saturated fat. Calorie (energy) and nutrient intakes up to the age of 10 years in the special Turku coronary risk factor intervention project.
99 The ONTARGET/TRANSCEND investigators. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients:. The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials.
100 Toivanen A, Toivanen P. Reactive arthritis.
101 Uibu T et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis.
102 Uusimaa P et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
103 Vartia A et al. Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation.
104 Vasankari T et al. Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations.
105 Vesalainen R. Hillitön hyperventilaatio.
106 Viikari J. Are our children fit or fat?
107 Viikari J. Erittäin kalliit lääkehoidot - polttopisteessä Fabryn tauti.
108 Viikari J. Preventiivisen pitkäaikaisen lääkehoidon lisääntyminen - esimerkkinä statiinit.
109 Viikari J. Diabetes ja seerumin lipidit.
110 Viikari JSA et al. Risk factors for coronary heart disease in children and young adults.
111 Vikman S et al. Improved adherence to practice guidelines yields better outcome in high-risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies.
112 Virtanen R. Paheneva hengenahdistus ja muuttumaton EKG.
113 Virtanen R et al. Increased pulse pressure is associated with reduced baroreflex sensitivity.
114 Virtanen R et al. Beat-to-beat oscillations in pulse pressure.
115 Virtanen R et al. Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin.
116 Virtanen T et al. Veren glukoosipitoisuuden jatkuva seuranta tyypin 1 diabeteksen hoidossa.
117 Vuopio-Varkila J, Kotilainen P. Metisilliiniresistentti staphylococcus aureus (MRSA).
118 Vuorinen T et al. Interstitial pneumonitis and coinfection of human herpesvirus 6 and Pneumocystis carinii in a patient with hypogammaglobulinemia.
119 Vähätalo MA et al. Cellular phone transferred self blood glucose monitoring: prerequisites for positive outcome.
120 Wachtell K et al. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function. The losartan intervention for endpoint reduction in hypertension (LIFE) study.
121 Williams JD et al. The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.
122 Yli-Kerttula T. Reactive Arthritis. Long-term Prognosis and Antimicrobial Treatment.
123 Yli-Kerttula T et al. Voidaanko reaktiivisen artriitin ennusteeseen vaikuttaa?
Julkaisutietokanta 26.10.2005 Publications Data Base 26.10.2005